Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240678632> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4240678632 endingPage "S125" @default.
- W4240678632 startingPage "S125" @default.
- W4240678632 abstract "In CHERISH, a Phase 3, randomized, double-blind, sham-controlled study (NCT02292537), nusinersen demonstrated significant and clinically meaningful improvement in motor function vs sham control in children with later-onset SMA. Within CHERISH, nusinersen was associated with reduced caregiver impact and less decline in HRQoL vs sham control. Children who completed CHERISH were eligible to enrol in the SHINE open-label extension study (NCT02594124); all participants receive nusinersen 12 mg every 4 months after a protocol amendment. SHINE interim data from 27 August 2019 were evaluated. ACEND and PedsQL Generic Core and Neuromuscular Module (NM) were administered to caregivers of children in CHERISH and SHINE to assess the effects of longer-term treatment with nusinersen on caregiver impact and HRQoL. Higher scores (range 0–100) in the ACEND and PedsQL scales indicate reduced caregiver impact and improved HRQoL. ACEND scores among caregivers improved (mean change [95% CI] from baseline of CHERISH to Day 1170) for the nusinersen-treated group in CHERISH/SHINE (n=67) in 5/7 subdomains: Feeding/Grooming/Dressing: 10.3 (5.99,14.54), Sitting/Playing: 1.1 (-2.18,4.45), Transfers: 3.5 (-0.68,7.70), Mobility: 5.0 (-0.47,10.45), and Finance: 0.7 (-3.76,5.25). Those treated with nusinersen in CHERISH/SHINE who were younger at first dose (≥2–<3.5 y, and ≥3.5–<5 y) showed greater benefits in caregiver impact than older children (≥5–<9.5 y) in 6/7 ACEND subdomains. PedsQL generic total score improved from baseline of CHERISH to Day 1170 for children treated with nusinersen in CHERISH/SHINE (n=63): mean (95% CI) change was 2.3 (-1.08,5.72); whereas the PedsQL NM score stabilized over time: -0.2 (-3.79,3.49). In addition to significant and clinically meaningful improvements in motor function, nusinersen was associated with reduced impact for caregivers and improvements in HRQoL for children with later-onset SMA over 3 years as measured by the ACEND and PedsQL, respectively." @default.
- W4240678632 created "2022-05-12" @default.
- W4240678632 creator A5003567567 @default.
- W4240678632 creator A5012502548 @default.
- W4240678632 creator A5041168644 @default.
- W4240678632 creator A5067331809 @default.
- W4240678632 creator A5075322351 @default.
- W4240678632 creator A5081705835 @default.
- W4240678632 creator A5085420791 @default.
- W4240678632 date "2020-10-01" @default.
- W4240678632 modified "2023-10-16" @default.
- W4240678632 title "SMA – THERAPY" @default.
- W4240678632 doi "https://doi.org/10.1016/j.nmd.2020.08.268" @default.
- W4240678632 hasPublicationYear "2020" @default.
- W4240678632 type Work @default.
- W4240678632 citedByCount "3" @default.
- W4240678632 countsByYear W42406786322021 @default.
- W4240678632 countsByYear W42406786322022 @default.
- W4240678632 countsByYear W42406786322023 @default.
- W4240678632 crossrefType "journal-article" @default.
- W4240678632 hasAuthorship W4240678632A5003567567 @default.
- W4240678632 hasAuthorship W4240678632A5012502548 @default.
- W4240678632 hasAuthorship W4240678632A5041168644 @default.
- W4240678632 hasAuthorship W4240678632A5067331809 @default.
- W4240678632 hasAuthorship W4240678632A5075322351 @default.
- W4240678632 hasAuthorship W4240678632A5081705835 @default.
- W4240678632 hasAuthorship W4240678632A5085420791 @default.
- W4240678632 hasConcept C142724271 @default.
- W4240678632 hasConcept C15744967 @default.
- W4240678632 hasConcept C166957645 @default.
- W4240678632 hasConcept C1862650 @default.
- W4240678632 hasConcept C2776370487 @default.
- W4240678632 hasConcept C2776957806 @default.
- W4240678632 hasConcept C71924100 @default.
- W4240678632 hasConcept C95457728 @default.
- W4240678632 hasConceptScore W4240678632C142724271 @default.
- W4240678632 hasConceptScore W4240678632C15744967 @default.
- W4240678632 hasConceptScore W4240678632C166957645 @default.
- W4240678632 hasConceptScore W4240678632C1862650 @default.
- W4240678632 hasConceptScore W4240678632C2776370487 @default.
- W4240678632 hasConceptScore W4240678632C2776957806 @default.
- W4240678632 hasConceptScore W4240678632C71924100 @default.
- W4240678632 hasConceptScore W4240678632C95457728 @default.
- W4240678632 hasLocation W42406786321 @default.
- W4240678632 hasOpenAccess W4240678632 @default.
- W4240678632 hasPrimaryLocation W42406786321 @default.
- W4240678632 hasRelatedWork W2072848173 @default.
- W4240678632 hasRelatedWork W2461350637 @default.
- W4240678632 hasRelatedWork W2607879131 @default.
- W4240678632 hasRelatedWork W2726132750 @default.
- W4240678632 hasRelatedWork W2748952813 @default.
- W4240678632 hasRelatedWork W2899084033 @default.
- W4240678632 hasRelatedWork W2905394510 @default.
- W4240678632 hasRelatedWork W2960386832 @default.
- W4240678632 hasRelatedWork W3085278910 @default.
- W4240678632 hasRelatedWork W3094531818 @default.
- W4240678632 hasVolume "30" @default.
- W4240678632 isParatext "false" @default.
- W4240678632 isRetracted "false" @default.
- W4240678632 workType "article" @default.